Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

Trial Profile

Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs GTS 21 (Primary)
  • Indications Unspecified
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2017 Planned initiation date changed from 29 Sep 2017 to 29 Sep 2018.
    • 27 Jul 2017 Planned initiation date changed from 29 Jun 2017 to 29 Sep 2017.
    • 27 Jan 2017 Planned End Date changed from 1 Dec 2018 to 29 Dec 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top